These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 8169988)

  • 41. Erythropoietin: biological aspects and clinical usefulness.
    Liberato NL; Costa A; Barosi G
    Haematologica; 1990; 75(4):346-62. PubMed ID: 2276680
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vivo effects of recombinant human erythropoietin on circulating human hemopoietic progenitor cells.
    Ganser A; Bergmann M; Völkers B; Grützmacher P; Scigalla P; Hoelzer D
    Exp Hematol; 1989 Jun; 17(5):433-5. PubMed ID: 2714423
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Human recombinant erythropoietin (rH-EPO) in chronic hemodialysis patients].
    Jalil R; Vaccarezza A; Jara A; Lira P; Vial S; Serrano V
    Rev Med Chil; 1990 Jun; 118(6):629-34. PubMed ID: 1775783
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Influence of erythropoietin treatment on 2,3-bisphosphoglycerate and O2-affinity of red blood cells in children with renal anemia.
    Rapoport I; Engelhardt I; Drung I; Holzhütter H; Schmidt G
    Biomed Biochim Acta; 1990; 49(2-3):S280-3. PubMed ID: 2386518
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment of anaemia of progressive renal failure with recombinant human erythropoietin. A preliminary report.
    Salim KA; Salim S; Mathew T
    J Assoc Physicians India; 1992 Jan; 40(1):42-3. PubMed ID: 1634463
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Erythropoietin titers in health and disease.
    Erslev AJ
    Semin Hematol; 1991 Jul; 28(3 Suppl 3):2-7; discussion 7-8. PubMed ID: 1891720
    [No Abstract]   [Full Text] [Related]  

  • 47. Resistance to recombinant human erythropoietin therapy: a real clinical entity?
    Stivelman JC
    Semin Nephrol; 1989 Mar; 9(1 Suppl 2):8-11. PubMed ID: 2669085
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A mouse model for an erythropoietin-deficiency anemia.
    Zeigler BM; Vajdos J; Qin W; Loverro L; Niss K
    Dis Model Mech; 2010; 3(11-12):763-72. PubMed ID: 20959632
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment of renal anemia, 1960-1990.
    Koch KM; Frei U
    Adv Nephrol Necker Hosp; 1991; 20():19-30. PubMed ID: 2063711
    [No Abstract]   [Full Text] [Related]  

  • 50. Human recombinant erythropoietin in the treatment of anaemia in chronic haemodialysis patients.
    Sulková S; Kvasnicka J; Kasl M; Kozlová J; Podrouzek P; Bartûsková J; Válek A
    Czech Med; 1990; 13(2-3):98-106. PubMed ID: 2245762
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment of the anemia of progressive renal failure with recombinant human erythropoietin.
    Eschbach JW; Kelly MR; Haley NR; Abels RI; Adamson JW
    N Engl J Med; 1989 Jul; 321(3):158-63. PubMed ID: 2747747
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Extrinsic coagulation pathway in peritoneally dialyzed patients treated with erythropoietin].
    Małyszko J; Małyszko JS; Suchowierska E; Pawlak K; Myśliwiec M
    Przegl Lek; 2002; 59(3):139-41. PubMed ID: 12184025
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Erythropoietin.
    Bunn HF
    Cold Spring Harb Perspect Med; 2013 Mar; 3(3):a011619. PubMed ID: 23457296
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Erythropoietin in cardiac surgery.
    Helm RE; Gold JP; Rosengart TK; Zelano JA; Isom OW; Krieger KH
    J Card Surg; 1993 Sep; 8(5):579-606. PubMed ID: 8219540
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical observation on the treatment of male neoplastic anemia with Yixuesheng capsule combined with recombination human erythropoietin.
    Cheng Z; Wu JL; Chen JF
    Chin J Integr Med; 2009 Feb; 15(1):63-5. PubMed ID: 19271173
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Renoprotective effect of erythropoietin (EPO): possibly via an amelioration of renal hypoxia with stimulation of angiogenesis in the kidney.
    Kang DH; Park EY; Yu ES; Lee YS; Yoon KI
    Kidney Int; 2005 May; 67(5):1683. PubMed ID: 15840013
    [No Abstract]   [Full Text] [Related]  

  • 57. Erythropoietin: physiologic basis for clinical applications.
    Schuster SJ; Caro J
    Vox Sang; 1993; 65(3):169-79. PubMed ID: 8249358
    [No Abstract]   [Full Text] [Related]  

  • 58. [Biological and therapeutic properties of erythropoietin].
    Zak KP; Butenko AK; Anuchin AN
    Lik Sprava; 2002; (8):113-20. PubMed ID: 12669561
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The cellular biology of erythropoietin receptors.
    Lappin T
    Oncologist; 2003; 8 Suppl 1():15-8. PubMed ID: 12626783
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Some aspects of pleiotropic activity of erythropoietin].
    Switalski M; Małecki R
    Pol Arch Med Wewn; 2004 Oct; 112 Spec No():81-8. PubMed ID: 15669205
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.